Accretion Nutraveda Profile
Key Indicators
- Authorised Capital ₹ 3.60 M
as on 16-11-2024
- Paid Up Capital ₹ 3.60 M
as on 16-11-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.99 Cr
as on 16-11-2024
- Revenue 72.72%
(FY 2024)
- Profit 260.28%
(FY 2024)
- Ebitda 81.39%
(FY 2024)
- Net Worth 409.41%
(FY 2024)
- Total Assets 14.90%
(FY 2024)
About Accretion Nutraveda
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.60 M and a paid-up capital of Rs 3.60 M.
The company currently has active open charges totaling ₹1.99 Cr.
Harshad Rathod, Hardik Prajapati, Mayur Sojitra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290GJ2021PTC121216
- Company No.
121216
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Accretion Nutraveda?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshad Rathod  | Director | 16-Mar-2021 | Current |
| Hardik Prajapati | Director | 16-Mar-2021 | Current |
| Mayur Sojitra | Director | 16-Mar-2021 | Current |
| Vivek Patel | Director | 31-Mar-2021 | Current |
| Ankurkumar Patel | Director | 31-Mar-2021 | Current |
Financial Performance of Accretion Nutraveda.
Accretion Nutraveda Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 72.72% increase. The company also saw a substantial improvement in profitability, with a 260.28% increase in profit. The company's net worth Soared by an impressive increase of 409.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accretion Nutraveda?
Unlock access to Accretion Nutraveda's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Accretion Pharmaceuticals LimitedActive 1 year 30 daysHarshad Rathod, Hardik Prajapati and 2 more are mutual person
- Accresha Lifecare Private LimitedActive 3 years 1 month
Hardik Prajapati and Mayur Sojitra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 31 May 2021 | ₹1.99 Cr | Open |
How Many Employees Work at Accretion Nutraveda?
Accretion Nutraveda has a workforce of 0 employees as of Oct 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accretion Nutraveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accretion Nutraveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
